Laura Van Vaeck
Co-founder & Director, Regulatory & Startup
With a career spanning hands-on clinical practice and senior roles in global CROs, Laura Van Vaeck brings a unique blend of clinical insight and regulatory expertise to medical device and in vitro diagnostic development.
At Franklyn Health, she leads regulatory and startup strategy, helping sponsors de-risk programmes, streamline approvals and accelerate study timelines. Previously at ICON plc and IQVIA, Laura shaped clinical and regulatory strategies for device and diagnostic studies across multiple therapeutic areas. She advised sponsors on optimal MDR and IVDR pathways, designed startup models that improved speed and predictability, and was recognised as a subject matter expert trusted to guide global portfolios.
Her international experience gives her a deep understanding of regulatory environments worldwide, while her foundation as a physiotherapist in musculoskeletal and orthopaedic care ensures study designs remain closely aligned with patient needs. This unique combination enables Laura to bridge science, regulation and clinical practice—helping sponsors achieve faster, more reliable evidence generation and deliver safe, effective technologies to patients.